Allworth Financial’s Starling Oncology STLN Stock Holding History
Bought
Maintained
Sold
Other funds holding STLN
JAIC
Allworth Financial's STLN Position: Q3 2026 in Review
Allworth Financial reduced its Starling Oncology (STLN) stake by 21% in Q3 2026, selling an estimated $1.16K and leaving 744 shares worth $4.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4473.
Allworth Financial first reported a position in STLN in Q3 2025 and has held it in 5 quarters since. The position peaked at $5.09K in Q2 2026. 129 funds tracked by Wall St. Rank hold STLN as of Q3 2026.
- Allworth Financial held 744 shares of Starling Oncology worth $4.7K as of Q3 2026.
- Allworth Financial sold 194 Starling Oncology shares in Q3 2026, an estimated $1.16K.
- Starling Oncology made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #4473 holding.
- Allworth Financial first reported a position in Starling Oncology in Q3 2025 and has held it in 5 quarters since.
- Allworth Financial's Starling Oncology position peaked at $5.09K in Q2 2026.
- 129 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.
Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.